Surgeon Dorr Keeps Heat On Zimmer, Criticizing The Firm’s Communications
This article was originally published in The Gray Sheet
Executive Summary
Despite ambitious efforts to overhaul its compliance program, Zimmer's response to an industry-wide Department of Justice settlement has been sub-par in the eyes of orthopedic surgeons and threatens to harm the company in the long term, says prominent surgeon Larry Dorr
You may also be interested in...
Zimmer Marks Progress Toward Relaunch Of Surgical Devices, Durom Cup
Zimmer hopes to reintroduce certain recalled orthopedic surgical products by early next year, the company said during its Oct. 23 third-quarter earnings call
Zimmer Marks Progress Toward Relaunch Of Surgical Devices, Durom Cup
Zimmer hopes to reintroduce certain recalled orthopedic surgical products by early next year, the company said during its Oct. 23 third-quarter earnings call
Stryker Takes Government To Court, Alleging Abuse Of Subpoena Power
Stryker is asking a federal district court to rein in the government's investigation into the company's orthopedic device sales and marketing practices, claiming HHS is abusing the subpoena process